Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine

Journal of Clinical Virology

Volumn 47, Issue 1, 2010, Pages 97-99

  Mansour, Wael ^a,b   Ducancelle, Alexandra ^a,b   Le Gal, Frédéric ^c   Le Guillou Guillemette, Hélène ^a,b   Abgueguen, Pierre ^b   Pivert, Adeline ^a,b   Calès, Paul ^a,b   Gordien, Emmanuel ^c   Lunel, Françoise ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c EA3406   (France)

Author keywords

Chronic hepatitis Delta; Pegylated interferon; Seroconversion anti HBs; Tenofovir disoproxil fumarate

Indexed keywords

EMTRICITABINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PEGINTERFERON; PEGINTERFERON ALPHA2A; TENOFOVIR DISOPROXIL; VIRUS DNA; VIRUS RNA;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DELTA AGENT HEPATITIS; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER HISTOLOGY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEROCONVERSION; TREATMENT RESPONSE;

ADENINE; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; DEOXYCYTIDINE; DNA, VIRAL; DRUG THERAPY, COMBINATION; HEPATITIS B; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; POLYETHYLENE GLYCOLS; RNA, VIRAL; TREATMENT OUTCOME;

EID: 72049093205     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.09.027     Document Type: Article

References (12)

1. Rizzetto M., Canese M.G., Aricò S., Crivelli O., Trepo C., Bonino F., et al. Immunofluorescence detection of a new antigen-antibody system delta/anti-delta associated to the hepatitis B virus in the liver and the serum of HBs-Ag carriers. Gut 18 (1977) 997-1003
2. Hsieh T.H., Liu C.J., Chen D.S., and Chen P.J. Natural course and treatment of hepatitis D virus infection. J Formos Med Assoc 105 (2006) 869-881
3. Farci P. Delta hepatitis: an update. J Hepatol 39 (2003) S212-S219
4. Castelnau C., Le Gal F., Ripault M.P., Gordien E., Martinot-Peignoux M., Boyer N., et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 44 (2006) 728-735
5. Le Gal F., Gordien E., Affolabi D., Hanslik T., Alloui C., Dény P., et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 43 (2005) 2363-2369
6. Radjef N., Gordien E., Ivaniushina V., Gault E., Anaïs P., Drugan T., et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a Deltavirus genus of at least seven major clades. J Virol 78 (2004) 2537-2544
7. Williams V., Brichler S., Radjef N., Lebon P., Goffard A., Hober D., et al. Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. J Gen Virol 90 (2009) 2759-2767
8. Bozdayi A., Aslan N., Bozdayi G., Türkyilmaz A.R., Sengezer T., Wend U., et al. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch Virol 149 (2004) 2115-2129
9. Farci P., Roskams T., Chessa L., Peddis G., Mazzoleni A.P., Scioscia R., et al. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology 126 (2004) 1740-1749
10. Gozlan J., Lacombe K., Gault E., Raguin G., and Girard P.M. Complete cure of HBV-HDV co-infection after 24 weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV. J Hepatol 50 (2009) 432-434
11. Van Bömmel F., Wünsche T., Mauss S., Reinke P., Bergk A., Schürmann D., et al. Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology 40 (2004) 1421-1425
12. Wursthorn K., Lutgehetmann M., Dandri M., Volz T., Buggisch P., Zollner B., et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 44 (2006) 675-684